European equities traded in the US as American depositary receipts were tracking higher late Monday morning, rising 0.24% to 1,407.61 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and accommodations booking site trivago (TRVG), which climbed 10% and 5.1%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and internet browser company Opera (OPRA), which rose 4.7% and 3.8%, respectively.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which dropped 7.7% and 4.7%, respectively. They were followed by telecommunications operator Telefonica (TEF) and pharmaceutical company Novo Nordisk (NVO), which were down 3.1% and 1.7%, respectively.
From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and cruise line operator Carnival (CUK), which advanced 9.1% and 8.5%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Silence Therapeutics (SLN), which were up 5.3% and 4.9%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and utilities company National Grid (NGG), which fell 12% and 4.2%, respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which lost 2.3% and 1.7%, respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。